AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 9804219
Drug: Micronized 17beta‐oestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized 17beta‐oestradiol 4 mg/day with GnRHa suppression
Trial: 9804219
Drug: Micronized 17beta‐oestradiol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micronized 17beta‐oestradiol 6 mg/day without GnRHa suppression
Trial: 8014529
Drug: Normal saline
RxNorm normalized name: Normal Saline Flush
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normal saline 2 mL, IM (Control)
Trial: 2809913
Drug: High-dose vitamin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose vitamin D2 supplementation (2000 IU/day)
Trial: 30371146
Drug: 1,500 mg/day
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1,500 mg/day of GRE for 3 days
Trial: 30641348
Drug: Combination with
RxNorm normalized name: Iron in combination with folic acid
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination with antidepressants
Trial: 30641348
Drug: Internet based
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Internet based cognitive‐behavioral therapy
Trial: 22807519
Drug: Balapiravir 3000
RxNorm normalized name: Balapiravir
DrugBank: Balapiravir (DB12283)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Balapiravir 3000 mg
Trial: 10661337
Drug: Adjuvant treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Adjuvant treatment with 5-fluorouracil (5-FU) and local-regional radiation
Trial: 8097214
Drug: Alpidem (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alpidem (25 mg twice daily during tapering)
Trial: 20660284
Drug: Hesperidin (800
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hesperidin (800 mg/day)
Trial: 20660284
Drug: Naringin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Naringin (500 mg/day)
Trial: 15777866
Drug: Functional recovery
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Functional recovery (defined in terms of neck pain intensity or work disability without medication use)
Trial: 8622107
Drug: Isepamicin 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isepamicin 7.5 mg/kg twice daily
Trial: 8622107
Drug: Amikacin 7.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amikacin 7.5 mg/kg twice daily
Trial: 31389210
Drug: Topical Cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Cyclosporine Nanoemulsion 0.05% (CN)
Trial: 31389210
Drug: Topical Cyclosporine
RxNorm normalized name: Cyclosporine
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical Cyclosporine Emulsion 0.05% (CE)
Trial: 25418605
Drug: Single-dose nilotinib
RxNorm normalized name: Nilotinib
DrugBank: Nilotinib (DB04868)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Single-dose nilotinib 600 mg with midazolam 4 mg
Trial: 2420106
Drug: Thyrotropin-releasing hormone
RxNorm normalized name: thyrotropin-releasing hormone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Thyrotropin-releasing hormone (TRH)
Trial: 19375008
Drug: Continuous oral
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous oral anticoagulation therapy (OAT)
Trial: 8157552
Drug: Famciclovir 125
RxNorm normalized name: famciclovir 125 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 125 mg
Trial: 8157552
Drug: Famciclovir 250
RxNorm normalized name: famciclovir 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 250 mg
Trial: 7778840
Drug: Famciclovir 750
RxNorm normalized name: famciclovir 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir 750 mg
Trial: 16163627
Drug: Famciclovir (all
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Famciclovir (all doses)
Trial: 3064772
Drug: Various treatments
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Various treatments in the DBCG programme
Trial: 31675437
Drug: 2 g
RxNorm normalized name: Molds 2 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2 g probenecid (PRO) + 600 mg tenofovir disoproxil fumarate (TDF) / 400 mg emtricitabine (FTC)
Trial: 28444112
Drug: Vemurafenib (960
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vemurafenib (960 mg twice a day)
Trial: 26178731
Drug: 1350 mg
RxNorm normalized name: HOMOSALATE 3060 mg in 45 mL / OCTOCRYLENE 4500 mg in 45 mL / OCTISALATE 2250 mg in 45 mL / AVOBENZONE 1350 mg in 45 mL TOPICAL CREAM [ZO Skin Health Daily Sheer Broad-Spectrum Sunscreen SPF 50 Water Resistant (40 Minutes)]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1350 mg encapsulated green tea extract (540 mg GTC) with 50 mg vitamin C, twice daily for 3 months
Trial: 9247776
Drug: Placebo, twice
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo, twice daily for 3 months
Trial: 23946601
Drug: Double-dose rabeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose rabeprazole (20 mg twice daily)
Trial: 23946601
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose amitriptyline + rabeprazole
Trial: 23946601
Drug: Double-dose rabeprazole
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Double-dose rabeprazole
Trial: 22118751
Drug: Green tea
RxNorm normalized name: Green Tea
DrugBank: Green tea leaf (DB14307)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Green tea extract (GTE) supplementation (640 mg polyphenols/d)
Trial: 16989023
Drug: Pegaptanib (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pegaptanib (0.3 mg injected into the eye every 6 weeks)
Trial: 12925219
Drug: NG‐methyl‐L‐arginine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: NG‐methyl‐L‐arginine
Trial: 9296229
Drug: Modified MIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Modified MIC regimen (cisplatin 100 mg/m2 on day 2, ifosfamide on day 1 with mitomycin)
Trial: 21175545
Drug: Beraprost sodium
RxNorm normalized name: beraprost sodium
DrugBank: Beraprost (DB05229)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beraprost sodium (BPS) 120 µg/day
Trial: 18410283
Drug: Midodrine (12.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Midodrine (12.5 mg three times per day for 2 days)
Trial: 23842215
Drug: Albumin (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albumin (8 g/L of removed ascites)
Trial: 12887341
Drug: Oral‐B40+ manual
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral‐B40+ manual brush
Trial: 7031187
Drug: Metoprolol (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoprolol (150 mg)
Trial: 10189005
Drug: Beta-blocker withdrawal
RxNorm normalized name: Beta Carotene
DrugBank: Beta carotene (DB06755)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-blocker withdrawal (24 hours after discontinuation of metoprolol)
Trial: 7749881
Drug: Atorvastatin 5
RxNorm normalized name: amlodipine-atorvastatin 5 mg-80 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Atorvastatin 5 mg
Trial: 6342354
Drug: Warfarin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin plus dipyridamole (400 mg/day)
Trial: 6342354
Drug: Warfarin plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Warfarin plus aspirin (500 mg/day)
Trial: 30496458
Drug: Rifampicin (with
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rifampicin (with peak concentration above 7 mg/L)
Trial: 17470017
Drug: Periodontal treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Periodontal treatment in group 2 (266 patients)
Trial: 9854159
Drug: Interferential current
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferential current (IFC) applied prior to UV treatment
Trial: 9854159
Drug: Interferential current
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferential current (IFC) applied in combination with UV-radiation
Trial: 9854159
Drug: Interferential current
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interferential current (IFC) applied after UV treatment
Trial: 7875472
Drug: midazolam (35
FDA approved: no
EMA approved: no
PMDA approved: no
Description: midazolam (35 micrograms/kg) and lidocaine spray (100 mg)
Trial: 213498
Drug: CP-20,961 administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CP-20,961 administered prior to challenge
Trial: 213498
Drug: CP-20,961 administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CP-20,961 administered 24 hours after challenge
Trial: 213498
Drug: CP-20,961 administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CP-20,961 administered 48 hours after challenge
Trial: 15502972
Drug: D-cycloserine 50
RxNorm normalized name: D-(+)-cycloserine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: D-cycloserine 50 mg/day
Trial: 8719441
Drug: Gn-RHa plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gn-RHa plus hGH therapy
Trial: 2624987
Drug: Other medical
RxNorm normalized name: Ether
DrugBank: Diethyl ether (DB13598)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Other medical treatment (Control)
Trial: 24948702
Drug: Targeted treatment
RxNorm normalized name: benzoyl peroxide 25 mg in 1 mL TOPICAL SWAB [SkinPharmacy Advanced Acne Therapy Targeted Treatment Wipes]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Targeted treatment
Trial: 23161357
Drug: bupivacaine 0.25%
RxNorm normalized name: BUPIVACAINE 0.25%/NS INJ 400ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine 0.25% (1 ml kg(‐1); Group B)
Trial: 23161357
Drug: bupivacaine plus
FDA approved: no
EMA approved: no
PMDA approved: no
Description: bupivacaine plus dexmedetomidine (1 μg kg(‐1); Group BD)
Trial: 21810198
Drug: Intervention group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intervention group discussed self-efficacy scores using the Long-Term Medication Behaviour Self-Efficacy Scale (LTMBSES)
Trial: 7717598
Drug: Dapsone-pyrimethamine (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dapsone-pyrimethamine (100 mg of dapsone plus 50 mg of pyrimethamine orally twice weekly)
Trial: 2288407
Drug: 0.15 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.15 mg/kg famotidine
Trial: 27863271
Drug: Combined hormonal
RxNorm normalized name: Parathyroid Hormone
DrugBank: Parathyroid hormone (DB05829)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Combined hormonal oral pill (30mcg ethinyl estradiol and 150mcg levonorgestrel for 84 days)
Trial: 24696010
Drug: UV‐A1 phototherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: UV‐A1 phototherapy (50 J/cm²) performed 4 times weekly for 3 months
Trial: 22978309
Drug: Cineole (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cineole (200 mg, three times per day for 6 months)
Trial: 19274793
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition with trace elements (TEs)
Trial: 19274793
Drug: Total parenteral
RxNorm normalized name: TPN - total parenteral nutrition
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Total parenteral nutrition (all groups)
Trial: 17525141
Drug: Hyperglycaemia (blood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Hyperglycaemia (blood glucose >8 mmol/l) in non-lacunar stroke
Trial: 11907944
Drug: Transdermal estradiol
RxNorm normalized name: estradiol Transdermal System
DrugBank: Estradiol (DB00783)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Transdermal estradiol delivery system A (twice a week)
Trial: 2518857
Drug: Omeprazole (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Omeprazole (20 mg o.m.)
Trial: 8023719
Drug: Histamine H2-receptor
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Histamine H2-receptor antagonists (cimetidine 400 mg q.d.s. or ranitidine 150 mg b.d.)
Trial: 12107216
Drug: Simvastatin (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Simvastatin (40 mg/d)
Trial: 19269130
Drug: Vaccine Safety
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine Safety Messages (VSM)
Trial: 19269130
Drug: Vaccine Information
RxNorm normalized name: Pertussis vaccine
DrugBank: Pertussis vaccine (DB15274)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vaccine Information Statement (VIS)
Trial: 1522839
Drug: 600 mg
RxNorm normalized name: mesna 600 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 600 mg of mifepristone
Trial: 7947424
Drug: Fentanyl 25
RxNorm normalized name: FENTANYL 25MCG/HR PATCH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 25 micrograms with morphine 0.25 mg
Trial: 7947424
Drug: Sufentanil 10
RxNorm normalized name: SUFentanil 100 MCG in 2 ML Injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sufentanil 10 micrograms with morphine 0.25 mg
Trial: 22028938
Drug: Killed whole-cell
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Killed whole-cell oral cholera vaccine (OCV)
Trial: 26155841
Drug: Smoking cessation
RxNorm normalized name: Zyban 150 MG Smoking Cessation 12 HR Extended Release Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Smoking cessation treatment navigators
Trial: 24011635
Drug: Test drug
RxNorm normalized name: URINE TEST DRUGS
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Test drug (newly developed lamivudine tablet)
Trial: 21119152
Drug: Home treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Home treatment model
Trial: 16096182
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate lotion
Trial: 16096182
Drug: Clobetasol propionate
RxNorm normalized name: Clobetasol Propionate
DrugBank: Clobetasol propionate (DB01013)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Clobetasol propionate emollient cream
Trial: 15898289
Drug: Lotion vehicle
RxNorm normalized name: meningococcal group B vaccine / Neisseria meningitidis serogroup B recombinant FHBP fusion protein antigen / Neisseria meningitidis serogroup B recombinant NHBA fusion protein antigen / Neisseria meningitidis serogroup B strain NZ98/254 outer membrane vesicle Prefilled Syringe [Bexsero]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lotion vehicle
Trial: 10821298
Drug: Low-dose oral
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose oral oestrogen (1 mg, 17-beta-estradiol)
Trial: 10821298
Drug: Oestrogen (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oestrogen (1 mg 17-beta-estradiol) in combination with low-dose (0.5 mg) continuous norethisterone acetate (NETA)
Trial: 10821298
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (Low-dose oral oestrogen)
Trial: 9007160
Drug: Acyclovir (dose-dependent)
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir (dose-dependent)
Trial: 31410633
Drug: Contezolid (MRX-I)
RxNorm normalized name: iobenguane I-131
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Contezolid (MRX-I) at therapeutic doses
Trial: 7531032
Drug: Electrostatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrostatic therapy (EST) with low voltage (200 to 1200 V)
Trial: 7531032
Drug: Electrostatic therapy
RxNorm normalized name: Monistat Simple Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Electrostatic therapy (EST) with high voltage (500 to 2500 V)
Trial: 1906610
Drug: Misoprostol 400
RxNorm normalized name: Misoprostol 400 microgram oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Misoprostol 400 micrograms twice daily
Trial: 27444426
Drug: Interviewer-administration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Interviewer-administration of the TAPS Tool
Trial: 27444426
Drug: Self-administration of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Self-administration of the TAPS Tool
Trial: 19456308
Drug: Intranasal midazolam
RxNorm normalized name: Midazolam
DrugBank: Midazolam (DB00683)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intranasal midazolam (MDZ) 5 mg
Trial: 2190897
Drug: Roxithromycin 150
RxNorm normalized name: roxithromycin 150 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Roxithromycin 150 mg b.i.d. p.o. for ten days
Trial: 2190897
Drug: Doxycycline 100
RxNorm normalized name: doxycycline 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline 100 mg b.i.d. p.o. for ten days
Trial: 30918030
Drug: High-intensity intervention
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-intensity intervention programme (weekly group sessions for 12 months)
Trial: 22496767
Drug: Caffeine ingestion
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine ingestion (3 mg kg(‐1); AM(CAFF) trial)
Trial: 9699585
Drug: Cimetidine 400
RxNorm normalized name: cimetidine 400 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cimetidine 400 mg intravenously before bypass and 33 mg/hr infusion after operation until the fifth postoperative day
Trial: 9699585
Drug: Conventional perioperative
RxNorm normalized name: ENSURE SURGERY PERIOPERATIVE KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional perioperative therapy
Trial: 8137335
Drug: Beta-carotene (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Beta-carotene (30 mg/day) plus retinyl palmitate (25,000 IU/day)
Trial: 2802363
Drug: Preventive treatment
RxNorm normalized name: STANNOUS FLUORIDE 0.004 g in 1 g DENTAL GEL [Enamelon Preventive Treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Preventive treatment with one of three different fixed drug combinations containing isoniazid
Trial: 108043
Drug: Ethane-1-hydroxy-1,1-diphosphonate (EHDP)
DrugBank: Etidronic acid (DB01077)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ethane-1-hydroxy-1,1-diphosphonate (EHDP) 4.4 mmol daily for 12 months
Trial: 108043
Drug: Placebo after
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo after 12 months of EHDP treatment
Trial: 108043
Drug: EHDP treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: EHDP treatment
Trial: 6385229
Drug: Azathioprine/steroids
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azathioprine/steroids
Trial: 21570352
Drug: Taxane-based regimen
RxNorm normalized name: Anacin Aspirin Regimen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Taxane-based regimen (T-ET): three cycles of docetaxel 100 mg/m² followed by three cycles of intravenous epirubicin 90 mg/m² and docetaxel 75 mg/m².
Trial: 21570352
Drug: Anthracycline regimen
RxNorm normalized name: Anacin Aspirin Regimen Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anthracycline regimen (FEC): six cycles of intravenous fluorouracil 500 mg/m², epirubicin 100 mg/m², and cyclophosphamide 500 mg/m² or fluorouracil 600 mg/m², epirubicin 75 mg/m², cyclophosphamide 900 mg/m².
Trial: 8811519
Drug: Calorie-dense milk
RxNorm normalized name: MILK
DrugBank: Cow milk (DB10543)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calorie-dense milk (5.0 kJ/ml with a protein-energy ratio of 11.0)
Trial: 1393487
Drug: Haemoccult screening
RxNorm normalized name: SUN PROTECTANTS/SCREENS,TOPICAL
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Haemoccult screening test for rectal cancers
Trial: 27249005
Drug: 300 U
RxNorm normalized name: lactase 3300 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 300 U BoNT‐A injection into the detrusor every six months
Trial: 25061252
Drug: Oral Pressure
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral Pressure Therapy (OPT) device
Trial: 22777041
Drug: ST-246 400
RxNorm normalized name: STS
DrugBank: Sodium tetradecyl sulfate (DB00464)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ST-246 400 mg
Trial: 22777041
Drug: ST-246 600
RxNorm normalized name: STS
DrugBank: Sodium tetradecyl sulfate (DB00464)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: ST-246 600 mg
Trial: 11821457
Drug: Anastrozole 1
RxNorm normalized name: anastrozole 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Anastrozole 1 mg orally once daily for 6 weeks
Trial: 11821457
Drug: Letrozole 2.5
RxNorm normalized name: letrozole 2.5 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Letrozole 2.5 mg orally once daily for 6 weeks
Trial: 1911657
Drug: Acyclovir (ACV)
RxNorm normalized name: Acyclovir
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir (ACV) ointment and placebo drops (AP)
Trial: 1911657
Drug: Placebo ointment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo ointment with steroid drops (PS)
Trial: 1911657
Drug: Acyclovir ointment
RxNorm normalized name: Acyclovir Ointment
DrugBank: Acyclovir (DB00787)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Acyclovir ointment with steroid drops (AS)
Trial: 9039254
Drug: Automatic NCPAP
RxNorm normalized name: AMMONIA,AROMATIC
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Automatic NCPAP titration (Horizon, DeVilbiss)
Trial: 9039254
Drug: Manual NCPAP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Manual NCPAP titration
Trial: 7960016
Drug: High cardiorespiratory
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High cardiorespiratory fitness (VO2peak 46.6 +/- 6.5 mL.kg-1.min-1)
Trial: 7960016
Drug: Moderate cardiorespiratory
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Moderate cardiorespiratory fitness (VO2peak 35.9 +/- 1.9 mL.kg-1.min-1)
Trial: 3236323
Drug: Twice daily
RxNorm normalized name: CAPSULE, TWICE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Twice daily nitrendipine (20 mg)
Trial: 3236323
Drug: Once daily
RxNorm normalized name: GEL, ONCE DAILY
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once daily nitrendipine (20 mg)
Trial: 25742730
Drug: Saquinavir/ritonavir 500/100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saquinavir/ritonavir 500/100 mg BID on days 1-7 and 1000/100 mg BID on days 8-14